GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Additional Paid-In Capital

DuoGenic StemCells (ROCO:7607) Additional Paid-In Capital : NT$0.00 Mil(As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Additional Paid-In Capital?


DuoGenic StemCells Additional Paid-In Capital Historical Data

The historical data trend for DuoGenic StemCells's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Additional Paid-In Capital Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
- - - -

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial - - - - -

DuoGenic StemCells Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

DuoGenic StemCells Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Additional Paid-In Capital
Comparable Companies
ROCO:4197 ROCO:6744 ROCO:6848 ROCO:4170 ROCO:6876 ROCO:6827 ROCO:6549 ROCO:6917 ROCO:6999 ROCO:6652 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
Website
https://www.dgsc.com.tw
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines